The role of progesterone receptors in breast cancer
Z Li, H Wei, S Li, P Wu, X Mao - Drug design, development and …, 2022 - Taylor & Francis
The progesterone receptor (PR) modulates estrogen receptors α (ERα) action in breast
cancer; it is an upregulated target gene of ER, and its expression is dependent on estrogen …
cancer; it is an upregulated target gene of ER, and its expression is dependent on estrogen …
The divergent effects of ovarian steroid hormones in the MCF-7 model for Luminal A breast cancer: Mechanistic leads for therapy
NT Telang - International Journal of Molecular Sciences, 2022 - mdpi.com
The growth modulating effects of the ovarian steroid hormones 17β-estradiol (E2) and
progesterone (PRG) on endocrine-responsive target tissues are well established. In …
progesterone (PRG) on endocrine-responsive target tissues are well established. In …
Progesterone receptor signaling promotes cancer associated fibroblast mediated tumorigenicity in ER+ breast cancer
Breast cancer progression involves intricate interactions between cancer cells and the tumor
microenvironment (TME). This study elucidates the critical role of progesterone receptor …
microenvironment (TME). This study elucidates the critical role of progesterone receptor …
Progesterone receptors in normal breast development and breast cancer
S Giulianelli, CA Lamb, C Lanari - Essays in Biochemistry, 2021 - portlandpress.com
Progesterone receptors (PR) play a pivotal role in many female reproductive tissues such as
the uterus, the ovary, and the mammary gland (MG). Moreover, PR play a key role in breast …
the uterus, the ovary, and the mammary gland (MG). Moreover, PR play a key role in breast …
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics
Recent advances have brought forth the complex interplay between tumor cell plasticity and
its consequential impact on drug resistance and tumor recurrence, both of which are critical …
its consequential impact on drug resistance and tumor recurrence, both of which are critical …
Hormone Metabolites and Herbal Bioactive Agents: Potential Drug Candidates for the Luminal A Breast Cancer subtype
NT Telang - Medical Research Archives, 2024 - esmed.org
Background: Hormone receptor positive, human epidermal growth factor receptor negative
Luminal A breast cancer subtype responds to targeted endocrine therapy, signal …
Luminal A breast cancer subtype responds to targeted endocrine therapy, signal …
[PDF][PDF] MiR-574-5p dysregulation in metastatic breast cancer through cell migration
O Doğan, Ş Linton, C Öztürk, O Murat - 2024 - ajbm.net
Breast cancer is the most frequently diagnosed malignancy among women worldwide. The
occurrence rate of metastasis is also increased. It's reported that 20–30% of breast cancer …
occurrence rate of metastasis is also increased. It's reported that 20–30% of breast cancer …